Fulcrum Therapeutics, Inc. Common Stock

Go to Fulcrum Therapeutics, Inc. Common Stock Website

$6.96

0.00 (0.00%)
Live
Previous Close

$6.96

Day Range

$0 - $0

Previous Day Range

$6.51 - $7.03

Market Cap

$369.4 million USD

Day Vol.

0

Previous Day Vol.

1.1 million

Currency

USD

Primary Exchange

Nasdaq

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, announced that it granted stock options to a new employee as an inducement to join the company.

Related tickers: FULC.

Read Full Article

Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, will release its third quarter 2024 financial results and host a conference call and webcast on November 13, 2024.

Related tickers: FULC.

Read Full Article
Trending Tickers

Please sign in to view